Group 1 - The company held its 12th meeting of the third Supervisory Board on March 28, 2025, with all three supervisors present, including one via telecommunication [2][4] - The meeting approved the draft of the 2025 Restricted Stock Incentive Plan, which aligns with relevant laws and regulations, aiming to motivate management and core personnel for sustainable development [3][5] - The plan will be submitted for shareholder meeting approval [5][7] Group 2 - The company also held its 12th meeting of the third Board of Directors on March 28, 2025, with all nine directors present [11][13] - The Board approved the draft of the 2025 Restricted Stock Incentive Plan and its summary, designed to attract and retain talent while aligning interests among shareholders, the company, and core teams [12][14] - The Board proposed to authorize the Board of Directors to handle matters related to the implementation of the incentive plan, which includes various responsibilities and adjustments as necessary [15][17] Group 3 - The company plans to hold its first temporary shareholder meeting of 2025 on April 17, 2025, using a combination of on-site and online voting [20][21] - The meeting will address the approval of the incentive plan and other related matters [19][20]
北京怡和嘉业医疗科技股份有限公司 第三届监事会第十二次 会议决议公告